When deciding which weight loss therapy is the best choice for you, it is important to understand the difference between the two options. Both therapies contain GLP-1 receptor agonist peptides while our GIP/GLP-1 Peptide therapy adds the benefits of the glucose-dependent insulinotropic polypeptide (GIP) receptor agonist peptide. Here’s what this difference means for you:
WEIGHT LOSS: In clinical trials comparing both of these peptide therapies, the following results were recorded:
Ultimately, if weight loss is your main goal (and you are not limited by budget), then the dual GIP/GLP-1 peptide therapy is probably the best fit for you. Otherwise, our GLP-1 therapy will most likely be your best option from a cost/pound lost perspective.
